Rocky Rollout Spells Trouble for Medicare Prescription Payment Plan
-
May 01, 2025
In the first two months of the new Medicare Prescription Payment Plan, a mere 0.4% of Medicare Part D beneficiaries have elected to participate in what the industry commonly refers to as the M3P. That’s lower than what many stakeholders projected for the program’s first year and far below CMS’s expectations of 6% of the individual Part D population, according to a recent analysis from Milliman Medicare Market Intelligence (MedIntel).
It’s unclear if enrollment will increase as the program continues to roll out, but early invoicing data suggests that members are slow to pay, which could discourage future efforts to boost enrollment.
Read more
© 2025 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.